Overview

Osteoporosis Treatment in Post-menopausal Women

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The study will be conducted to assess the depressive symptoms and related markers in the postmenopausal female after anti-osteoporosis treatment.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Taichung Veterans General Hospital
Treatments:
Alendronate
Raloxifene Hydrochloride
Criteria
Inclusion Criteria:

- Postmenopausal female

- Osteoporosis

Exclusion Criteria:

- Psychological disorders